HomeCompareIBND vs JNJ

IBND vs JNJ: Dividend Comparison 2026

IBND yields 2.65% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IBND wins by $3.6K in total portfolio value
10 years
IBND
IBND
● Live price
2.65%
Share price
$31.12
Annual div
$0.82
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.6K
Annual income
$314.02
Full IBND calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — IBND vs JNJ

📍 IBND pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIBNDJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IBND + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IBND pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IBND
Annual income on $10K today (after 15% tax)
$225.01/yr
After 10yr DRIP, annual income (after tax)
$266.92/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $436.70/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IBND + JNJ for your $10,000?

IBND: 50%JNJ: 50%
100% JNJ50/50100% IBND
Portfolio after 10yr
$21.8K
Annual income
$570.90/yr
Blended yield
2.61%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

IBND
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IBND buys
0
JNJ buys
0
No recent congressional trades found for IBND or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIBNDJNJ
Forward yield2.65%3.36%
Annual dividend / share$0.82$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$23.6K$20.0K
Annual income after 10y$314.02$827.78
Total dividends collected$2.9K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: IBND vs JNJ ($10,000, DRIP)

YearIBND PortfolioIBND Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,965$264.72$10,676$355.77+$289.00IBND
2$12,004$271.27$11,407$389.39+$597.00IBND
3$13,121$277.54$12,198$426.53+$923.00IBND
4$14,323$283.54$13,056$467.62+$1.3KIBND
5$15,615$289.27$13,987$513.12+$1.6KIBND
6$17,003$294.73$14,998$563.56+$2.0KIBND
7$18,493$299.92$16,098$619.52+$2.4KIBND
8$20,093$304.87$17,295$681.69+$2.8KIBND
9$21,809$309.57$18,599$750.82+$3.2KIBND
10$23,649$314.02$20,022$827.78+$3.6KIBND

IBND vs JNJ: Complete Analysis 2026

IBNDStock

The SPDRBloomberg International Corporate Bond ETF seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the Bloomberg Global Aggregate ex-USD > $1B: Corporate Bond IndexSeeks to provide a broad exposure to the global investment grade, fixed rate, fixed income corporate markets outside the United StatesThe securities in the Index must have a $1 billion USD equivalent market capitalization outstanding, have at least 1 year remaining, must be fixed rate (although zero coupon bonds and step-ups are permitted) and must be rated investment gradeMarket cap weighted and reconstituted on the last business day of the month

Full IBND Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this IBND vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IBND vs SCHDIBND vs JEPIIBND vs OIBND vs KOIBND vs MAINIBND vs ABBVIBND vs MRKIBND vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.